15-Deoxyspergualin and platelet aggregation in vitro.
J S
JS
Malyszko
J
J
Małyszko
M
M
Mysliwiec
A
A
Takada
D016022:Case-Control Studies; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects; D004347:Drug Interactions; D006146:Guanidines / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D066298:In Vitro Techniques; D016030:Kidney Transplantation / Q000009:adverse effects; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010974:Platelet Aggregation / Q000187:drug effects*; D006435:Renal Dialysis; D013927:Thrombosis / Q000209:etiology
D006146:Guanidines; D007166:Immunosuppressive Agents; D016572:Cyclosporine; C037258:gusperimus